Clinical assessment of GFR by testing blood creatinine lacks sufficient sensitivity for mild renal injury, whereas Cystatin C can respond sensitively to mild renal injury, and regular testing of Cystatin C in patients with DKD and DKD+NDKD allows for dynamic observation of disease progression. The gene discussed is CST3; the disease is diabetic kidney disease.